The potential of dried saliva spots for antidepressant drugs monitoring

Soares, Sofia; Rosado, Tiago; Barroso, Mário; Gallardo, Eugenia

http://hdl.handle.net/10400.26/49349

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
THE POTENTIAL OF DRIED SALIVA SPOTS FOR ANTIDEPRESSANT DRUGS MONITORING_Soares_Iberoamericano.pdf		71.8 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Introduction: Portugal has one of the highest rates of mental illness in Europe, and the consumption of antidepressants amongst its population has doubled between the years 2013 and 2016. Approximately 30 million packs of medication are prescribed and dispensed annually in this country to treat major depressive disorders. Therapeutic Drug Monitoring (TDM) is a practice established for a small number of drugs, for which there is a direct relationship between concentration and pharmacological effect at the site of action. Commonly, TDM involves measuring drug concentrations in serum, plasma or blood, being complemented with clinical observation measures to assess patient’s condition, support the individualization of therapy, detect changes in the patient´s pathophysiological status or the modification of the drug pharmacokinetics, but also to assess adherence to therapy. Methodology: The present work describes a methodology with great potential for TDM purposes, allowing the determination of antidepressants (fluoxetine, venlafaxine, citalopram, sertraline, paroxetine and metabolites) using 100 μL of oral fluid with dried saliva spots (DSS) and analysis by gas chromatography-tandem mass spectrometry (GC-MS/MS). Results: For both sampling and extraction with DSS, several parameters were optimized using the statistical tool Design of Experiments (DoE), namely: drying and extraction times, extraction solvent and volume. The final optimized conditions were: 1 hour of drying, 1 mL of methanol and 5 minutes of extraction. The method was validated showing linearity within the adopted therapeutic ranges, with limits of detection and quantification between 10 and 100 ng/mL. All validation parameters were assayed according to the SWGTOX guidelines. Discussion: This is the first work that uses DSS to extract antidepressants from oral fluid samples, proving to be a sensitive, simple and fast alternative to conventional techniques and samples used in TDM (solid phase extraction based procedures and plasma samples). It also reveals potential to be routinely applied in TDM and forensic toxicology purposes, as it has been successfully applied to the analysis of authentic patient samples.

Description

Comunicação apresentada no 10º Congresso Iberoamericano de Ciências Farmacêuticas, Coimbra, Outubro de 2023. Abstract da comunicação publicado na Acta Farmacêutica Portuguesa. vol. de Outubro 2023. ISSN 2182-3340.